Skip to main content
SpringerLink
Log in

Antibiotika und Chemotherapeutika

  • Chapter
Arzneiverordnungs-Report 2016

Zusammenfassung

Die Antibiotikaverordnungen zeigen 2015 gegenüber dem Vorjahr von der Gesamtmenge her keine wesentlichen Veränderungen. Bei den verschiedenen Substanzklassen sind stärkere Veränderungen bei Oralpenicillin (Rückgang), Amoxicillin/Clavulansäure, Moxifloxacin und Fosfomycin (Anstiege) zu beobachten. Ein leichter Anstieg ist erneut auch bei Oralcephalosporinen zu verzeichnen. Die systemisch wirksamen oralen Antimykotika Fluconazol und Itraconazol wurden häufiger verordnet, ebenso die antivirale Substanz Aciclovir. Bei den antiretroviralen Mitteln kam es zu einer sehr klaren relativen Mehrverordnung der neuen Substanzen, insbesondere der modernen Kombinationspräparate, die als Einzeltablette zur Verfügung stehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abo-Salem E, Fowler JC, Attari M, Cox CD, Perez-Verdia A, Panikkath R, Nugent K (2014): Antibiotic-induced cardiac arrhythmias. Cardiovasc Ther 32: 19–25

    Google Scholar 

  • Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz HH (2007): Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. J Antimicrob Chemother 60: 638–644

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2013): Empfehlungen zur Therapie akuter Atemwegsinfektionen und der ambulant erworbenen Pneumonie, 3. Auflage, Berlin

    Google Scholar 

  • Balfour JAB, Wiseman LR (1999): Moxifloxacin. Drugs 57: 363–373

    Google Scholar 

  • Bätzing-Feigenbaum J, Schulz M, Schulz M, Hering R, Kern WV (2016): Antibiotikaverordnung in der ambulanten Versorgung—Eine bevölkerungsbezogene Untersuchung in Deutschland zum regionalen, altersgruppenbezogenen Verbrauch von Cephalosporinen und Fluorchinolonen. Dtsch Ärztebl 113: 454–459

    Google Scholar 

  • Bell-Syer SEM, Hart R, Crawford F, Torgerson DJ, Tyrell W, Russell I (2006): Oral treatments for fungal infections of the skin of the foot (Cochrane Review). In: The Cochrane

    Google Scholar 

  • Library, Issue 1 2006. Oxford: Update Software

    Google Scholar 

  • Berner R, Steffen G, Toepfner N, Waldfahrer F, Windfuhr JP (2015): S2k-Leitlinie Therapie entzündlicher Erkrankungen der Gaumenmandeln—Tonsillitis. AWMF, 2015.http://www.awmf.org/uploads/tx_szleitlinien/017-024l_S2k_Tonsillitis_Gaumenmandeln_2015-08_01.pdf

  • Bin Abdulhak AA, Khan AR, Garbati MA, Qazi AH, Erwin P, Kisra S, Aly A, Farid T, El-Chami M, Wimmer AP (2015): Azithromycin and risk of cardiovascular death: a meta-analytic review of observational studies. Am J Ther 22: e122–129

    Google Scholar 

  • Brown KA, Khanafer N, Daneman N, Fisman DN (2013): Metaanalysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 57: 2326–2332

    Google Scholar 

  • Butler CC, Hood K, Kelly MJ, Goossens H, Verheij T, Little P, Melbye H, Torres A, Mölstad S, Godycki-Cwirko M, Almirall J, Blasi F, Schaberg T, Edwards P, Rautakorpi UM, Hupkova H, Wood J, Nuttall J, Coenen S (2010): Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. J Antimicrob Chemother 65: 2472–2478

    Google Scholar 

  • Cadena J, Nair S, Henao-Martinez AF, Jorgensen JH, Patterson JE, Sreeramoju PV (2011): Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections

    Google Scholar 

  • caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55: 5430–5432

    Google Scholar 

  • Courter JD, Baker WL, Nowak KS, Smogowicz LA, Desjardins LL, Coleman CI, Girotto JE (2010): Increased clinical failures when treating acute otitis media with macrolides:

    Google Scholar 

  • a meta-analysis. Ann Pharmacother 44: 471–478

    Google Scholar 

  • Cunha BA (2006): New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. Med Clin North Am 90: 1089–1107

    Google Scholar 

  • DAIG/ÖAG (2014): Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion. Version vom 13.5.2014. Internet:http://www.daignet.de/site-content/hiv-therapie/leitlinien-1/Deutsch_Osterreichische%20 Leitlinien%20zur%20antiretroviralen%20Therapie%20 der%20HIV_Infektion.pdf

  • DEGAM (2008): Rhinosinusitis—DEGAM-Leitlinie Nr. 10.http://www.degam.de/typo/uploads/media/Langfassung_Rhinosinusitis-005_gekuerzt.pdf

  • DEGAM (2009): Brennen beim Wasserlassen—DEGAM-Leitlinie Nr. 1. Update 2009. Internet: www.degam.de/uploads/media/Brennen_Langfassung_006gesch.pdf

  • Del Rosso JQ, Schlessinger J, Werschler P (2008): Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea. J Drugs Dermatol 7: 573–576

    Google Scholar 

  • Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Sferra TJ, Hernandez AV, Donskey CJ (2013): Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 68: 1951–1961

    Google Scholar 

  • Deutsche Gesellschaft für Urologie (2010): S-3 Leitlinie (AWMF-Register-Nr. 043/044) Harnwegsinfektionen: Epidemiologie, Diagnostik, Therapie und Management

    Google Scholar 

  • unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten.http://leitlinien.degam.de/uploads/media/10-07-29-V3_Endfassung_S3_LL_HWI_Langfassung_17._Juni_2010.pdf

  • Dobson J, Whitley RJ, Pocock S, Monto AS (2015): Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 385: 1729–1737

    Google Scholar 

  • European Medicines Agency (EMA) (2008): Presseerklärung zu Moxifloxacin vom 24. Juli 2008.http://www.emea. europa.eu/pdfs/human/press/pr/38292708en.pdf

  • Ewig S, Höffken G, Kern WV, Rohde G, Flick H, Krause R, Ott S, Bauer T, Dalhoff K, Gatermann S, Kolditz M, Krüger S, Lorenz J, Pletz M, de Roux A, Schaaf B, Schaberg T, Schütte H, Welte T (2016): Management of adult community-acquired pneumonia and prevention—update 2016. Pneumologie 70: 151–200

    Google Scholar 

  • Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML (2014): Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother 69: 1748–1754

    Google Scholar 

  • Fuller JD, Low DE (2005): A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 41: 118–121

    Google Scholar 

  • Garner SE, Eady EA, Popescu C, Newton J, Li WA (2003): Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev: CD002086

    Google Scholar 

  • GERMAP (2008): Antibiotika-Resistenz und -Verbrauch. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Herausgegeben von BVL/PEG/Infektiologie Freiburg. http://www.p-e-g.org/econtext/germap2008

  • GERMAP (2012): Antibiotika-Resistenz und -Verbrauch. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Herausgegeben von BVL/PEG/Infektiologie Freiburg.http://www.bvl.bund.de/SharedDocs/Downloads/05_Tierarzneimittel/germap2012.pdf?__blob=publicationFile&v=4

  • Goldberg O, Koren G, Landau D, Lunenfeld E, Matok I, Levy A (2013): Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations. J Clin Pharmacol 3: 991–995

    Google Scholar 

  • Goldberg O, Moretti M, Levy A, Koren G (2015): Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis. J Obstet Gynaecol Can 7: 150–156

    Google Scholar 

  • Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, Pau HW, Malin JP, Wutzler P, Doerr HW (2003): Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 26: 277–289

    Google Scholar 

  • Hof H (2006): Vaginale Candidose. Gynäkologe 39: 206–213

    Google Scholar 

  • Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ (2012): Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev: CD008965

    Google Scholar 

  • Kern WV, Dettenkofer M (2009): Nosokomiale Infektionen: Herausforderung MRSA und CDAD. Internist 50: 691–703

    Google Scholar 

  • Kresken M, Körber-Irrgang B, Biedenbach DJ, Batista N, Besard V, Cantón R, García-Castillo M, Kalka-Moll W, Pascual A, Schwarz R, Van Meensel B, Wisplinghoff H, Seifert H (2016): Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect 22: 63.e1–5

    Google Scholar 

  • Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M, Mierzecki A, Chlabicz S, Torres A, Almirall J, Davies M, Schaberg T, Mölstad S, Blasi F, De Sutter A, Kersnik J, Hupkova H, Touboul P, Hood K, Mullee M, O’Reilly G, Brugman C, Goossens H, Verheij T; GRACE consortium (2013): Amoxicillin for acute lower-respiratorytract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 13: 123–129

    Google Scholar 

  • Löfmark S, Edlund C, Nord CE (2012): Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 50 Suppl 1: S16–23

    Google Scholar 

  • Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, Vaeth M, Obel N (2007): Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med 146: 87–95

    Google Scholar 

  • Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H (2007): Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 369: 482–490

    Google Scholar 

  • Malhotra-Kumar S, van Heirstraeten L, Coenen S, Lammens C, Adriaenssens N, Kowalczyk A, Godycki-Cwirko M, Bielicka Z, Hupkova H, Lannering C, Mölstad S, Fernandez-Vandellos P, Torres A, Parizel M, Ieven M, Butler CC, Verheij T, Little P, Goossens H; GRACE study group (2016): Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study. J Antimicrob Chemother 2016 Jun 26 [Epub ahead of print]

    Google Scholar 

  • Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d’Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD; EuroSIDA study group (2003): Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362: 22–29

    Google Scholar 

  • Muthuri SG, Venkatesan S, Myles PR et al (2014): Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N-1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2: 395–404

    Google Scholar 

  • Paul M, Bishara J, Yahav D, Goldberg E, Neuberger A, Ghanem-Zoubi N, Dickstein Y, Nseir W, Dan M, Leibovici L (2015): Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. BMJ 350: h2219

    Google Scholar 

  • Reinel D, Plettenberg A, Seebacher C, Abeck D, Brasch J, Cornely O, Effendy I, Ginter-Hanselmayer G, Haake N, Hamm G, Hipler UC, Hof H, Korting HC, Mayser P, Ruhnke M, Schlacke KH, Tietz HJ (2008): Orale Candidiasis—Leitlinie der Deutschen Dermatologischen Gesellschaft und der Deutschsprachigen Mykologischen Gesellschaft. J Dtsch Dermatol Ges 6: 593–597

    Google Scholar 

  • Robert Koch-Institut (2015): Bericht zur Epidemiologie der Influenza in Deutschland Saison 2014/15. Internet: https://influenza.rki.de/Saisonbericht.aspx

  • Ruhe JJ, Menon A (2007): Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 51: 3298–3303

    Google Scholar 

  • Sahm DF, Johnes ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C (2000): Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe 1997–1998. J Antimicrob Chemother 45: 457–466

    Google Scholar 

  • Schmitz GR, Bruner D, Pitotti R, Olderog C, Livengood T, Williams J, Huebner K, Lightfoot J, Ritz B, Bates C, Schmitz M, Mete M, Deye G (2010): Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med 56: 283–287

    Google Scholar 

  • Simkó J, Csilek A, Karászi J, Lorincz I (2008): Proarrhythmic potential of antimicrobial agents. Infection 36:194–206

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Freiburg, Innere Medizin II/Infektiologie, Hugstetter Straße 55, 79106, Freiburg

    Prof. Dr. med. Winfried V. Kern

Authors
  1. Prof. Dr. med. Winfried V. Kern
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kern, W. (2016). Antibiotika und Chemotherapeutika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2016. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50351-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50351-5_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50350-8

  • Online ISBN: 978-3-662-50351-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation